Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The hippocampus as a central hub in ketamine’s antidepressant action: from molecules to circuit rewiring
    Published on 2025-11-25
    8 months ago
  • Orbitofrontal BDNF puts the brakes on alcohol intake and relapse
    Published on 2025-11-24
    8 months ago
  • The impact of collider bias on genetic prediction in psychotic disorders
    Published on 2025-11-20
    8 months ago
  • Reliable variability in subjective responses to parenteral hydromorphone administration: empirical confirmation of an opioid non-responder phenotype
    Published on 2025-11-17
    8 months ago
  • Altered amygdala and striatal responsivity and prediction error encoding of temporal reward dynamics in post-trauma psychopathology
    Published on 2025-11-16
    8 months ago
  • IN MEMORIAM: Nolan R. Williams, MD
    Published on 2025-11-14
    9 months ago
  • Polydrug overdose mortality caused by synthetic opioids and stimulants: current sex- and age-specific trajectories in United States national data for 2018–2024
    Published on 2025-11-13
    9 months ago
« Previous 1 … 31 32 33 34 35 … 143 Next »
Journal of Psychopharmacology
  • Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program
    Published on 2025-04-26
    1 year ago
  • Therapeutic effects of resveratrol on memory deficits in offspring of sleep-deprived rats: Involvement of hippocampal BDNF-TrkB pathways
    Published on 2025-04-24
    1 year ago
  • Peri-traumatic consumption of classic psychedelics is associated with lower anxiety and post-traumatic responses 3 weeks after exposure
    Published on 2025-04-21
    1 year ago
  • Daily supplementation with lemon verbena extract decreases subjective energy and parental reports of hyperactivity in children displaying sub-clinical attention deficit hyperactivity disorder-type behaviours: A randomised controlled trial
    Published on 2025-04-19
    1 year ago
  • Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers
    Published on 2025-04-19
    1 year ago
  • Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus
    Published on 2025-04-17
    1 year ago
  • Discriminating evidence – use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugs
    Published on 2025-04-17
    1 year ago
« Previous 1 … 31 32 33 34 35 … 150 Next »
European Neuropsychopharmacology
  • Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia
    Published on 2025-02-16
    1 year ago
  • Artificial intelligence in healthcare: Revolution or unfulfilled promise?
    Published on 2025-02-16
    1 year ago
  • Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years
    Published on 2025-02-16
    1 year ago
  • Whole-brain functional neuroimaging correlates of cognitive flexibility impairments in people with mental disorders: A transdiagnostic coordinate-based meta-analysis
    Published on 2025-02-16
    1 year ago
  • Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study
    Published on 2025-02-09
    1 year ago
  • Lack of antidepressant-like effect of imipramine, fluoxetine and ketamine in the forced swim test in mice: How much standardization does a positive control require?
    Published on 2025-02-05
    1 year ago
  • Disease continuum centered on Parkinson’s disease
    Published on 2025-02-05
    1 year ago
« Previous 1 … 31 32 33 34 35 … 168 Next »

   Pharma Pub